Idarubicin
Back to searchMolecule Structure
Scientific Name
Idarubicin
Description of the Drug
Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01177
http://www.drugbank.ca/drugs/DB01177
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Sandoz Inc, Teva Parenteral Medicines Inc, Teva Pharmaceuticals Usa, Hikma Pharmaceuticals Usa Inc, Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
| DNA topoisomerase II alpha | SINGLE PROTEIN | INHIBITOR | CHEMBL1806 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3750 | ||
| PharmGKB | PA449961 | ||
| Human Metabolome Database | HMDB0015308 | ||
| DrugBank | DB01177 | ||
| PubChem: Thomson Pharma | 14908709 | 14810780 | |
| PubChem | 42890 | ||
| LINCS | LSM-5769 | ||
| Nikkaji | J32.515E | ||
| PDBe | DM5 | ||
| BindingDB | 58490 | ||
| EPA CompTox Dashboard | DTXSID7023142 | ||
| DrugCentral | 1414 | ||
| Metabolights | MTBLC42068 | ||
| Brenda | 20307 | ||
| ChemicalBook | CB5283235 | ||
| Guide to Pharmacology | 7083 | ||
| rxnorm | IDARUBICIN | IDARUBICIN HYDROCHLORIDE | IDAMYCIN |
| ChEBI | 42068 | ||
| ZINC | ZINC000003920266 |
